Citations

Showing 10 of 108104 citations.

Compartment Syndrome following Below-Knee Amputation
Gerry, Adam S. , Christopher, Zachary K. , Patel, Karan A. , Kile, Todd A. , Bingham, Joshua S. , Patel, Karan , Bingham, Joshua S

Mayo Clinic

Case Reports in Orthopedics | February 21, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-7

10.1155/2022/1256823 | PMID 35237457 Get It

In the setting of below-knee amputation, compartment syndrome is a rare complication. Early clinical symptoms of an acute compartment syndrome following below-knee amputation can mimic or be masked by postoperative pain management. We present the case of a 38-year-old male with a significant past medical history of Proteus syndrome who underwent an elective transtibial below-knee amputation. Following surgery, the patient had extensive postoperative pain and high pain medication requirements and returned to the operating room for irrigation and debridement due to suspicion of an infection. Upon return to the operating room to manage the infection, the necrotic tissue was discovered and removed which had developed due to a suspected missed acute compartment syndrome. The necrotic tissue secondary to the compartment syndrome subsequently resulted in infection. Multiple irrigation and debridement procedures were performed to further manage the infection, and ultimately, the patient was deemed stable for discharge. Acute compartment syndrome (ACS) following below-knee amputation (BKA) is a rarely documented but critical complication. This case describes the unique setting in which a compartment syndrome can be masked due to postoperative pain management and infection. Orthopedic surgeons should be aware of the varying risk factors and presentations of an acute compartment syndrome (ACS) as it can occur and is a devastating complication.
Myotonia in MuSK Myasthenia Gravis: A Unique Electrodiagnostic Finding
Skolka, Michael P., Lamb, Chris, Klein, Christopher J., Rubin, Devon I., Laughlin, Ruple S., Lamb, Christopher J. , Skolka, Michael , Lamb, Christopher J , Skolka, Michael P , Lamb, Chris, Klein, Christopher J., Rubin, Devon I., Laughlin, Ruple S.

Mayo Clinic

Journal of Clinical Neuromuscular Disease | February 21, 2022 | Volume: 23 | Issue: 3 | Pages: 165-166

10.1097/cnd.0000000000000350 | PMID 35188919 Get It

Hospital Variation in Management and Outcomes of Acute Respiratory Distress Syndrome Due to COVID-19
Johnson, Shelsey W., Garcia, Michael A., Sisson, Emily K. Q., Sheldrick, Christopher R., Kumar, Vishakha K., Boman, Karen, Bolesta, Scott, Bansal, Vikas, Lal, Amos, Domecq, J. P., Melamed, Roman R., Christie, Amy B., Husain, Abdurrahman, Yus, Santiago, Gajic, Ognjen, Kashyap, Rahul, Walkey, Allan J., Group, from the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator, Bansal, Vikas , Bolesta, Scott , Lal, Amos , Kaur, Nirmaljot , Заболотских, И. Б. , Tawheed, Ahmed , Lal, Amos , Bansal, Vikas , Kaur, Nirmaljot , Domecq Graces, Juan Pablo , Johnson, Shelsey W., Garcia, Michael A., Sisson, Emily K. Q., Sheldrick, Christopher R., Kumar, Vishakha K., Boman, Karen, Bansal, Vikas, Lal, Amos, Melamed, Roman R., Christie, Amy B., Husain, Abdurrahman, Yus, Santiago, Gajic, Ognjen, Kashyap, Rahul, Walkey, Allan J., Group, from the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator

Mayo Clinic

Critical Care Explorations | February 21, 2022 | Volume: 10 | Issue: 2 | Pages: e0638

10.1097/cce.0000000000000638 | PMID 35211681 Get It

OBJECTIVES: To describe hospital variation in use of “guideline-based care” for acute respiratory distress syndrome (ARDS) due to COVID-19. DESIGN: Retrospective, observational study. SETTING: The Society of Critical Care Medicine’s Discovery Viral Infection and RESPIRATORY ILLNESS UNIVERSAL STUDY COVID-19 REGISTRY. PATIENTS: Adult patients with ARDS due to COVID-19 between February 15, 2020, and April 12, 2021. INTERVENTIONS: Hospital-level use of “guideline-based care” for ARDS including low-tidal-volume ventilation, plateau pressure less than 30 cm H2O, and prone ventilation for a Pao 2/Fio 2 ratio less than 100. MEASUREMENTS AND MAIN RESULTS: Among 1,495 adults with COVID-19 ARDS receiving care across 42 hospitals, 50.4% ever received care consistent with ARDS clinical practice guidelines. After adjusting for patient demographics and severity of illness, hospital characteristics, and pandemic timing, hospital of admission contributed to 14% of the risk-adjusted variation in “guideline-based care.” A patient treated at a randomly selected hospital with higher use of guideline-based care had a median odds ratio of 2.0 (95% CI, 1.1–3.4) for receipt of “guideline-based care” compared with a patient receiving treatment at a randomly selected hospital with low use of recommended therapies. Median-adjusted inhospital mortality was 53% (interquartile range, 47–62%), with a nonsignificantly decreased risk of mortality for patients admitted to hospitals in the highest use “guideline-based care” quartile (49%) compared with the lowest use quartile (60%) (odds ratio, 0.7; 95% CI, 0.3–1.9; p = 0.49). CONCLUSIONS: During the first year of the COVID-19 pandemic, only half of patients received “guideline-based care” for ARDS management, with wide practice variation across hospitals. Strategies that improve adherence to recommended ARDS management strategies are needed.
Improving In-Hospital Patient Rescue: What Are Studies on Early Warning Scores Missing? A Scoping Review
Esmaeilzadeh, Sarvie, Lane, Conor M., Gerberi, Danielle J., Wakeam, Elliot, Pickering, Brian W., Herasevich, Vitaly, Hyder, Joseph A., Lane, Conor M. , Esmaeilzadeh, Sarvie , Lane, Conor M., Gerberi, Danielle J., Wakeam, Elliot, Pickering, Brian W., Herasevich, Vitaly, Hyder, Joseph A.

Mayo Clinic

Critical Care Explorations | February 21, 2022 | Volume: 4 | Issue: 2 | Pages: e0644

10.1097/cce.0000000000000644 | PMID 35224506 Get It

OBJECTIVES: Administrative and clinical efforts to improve hospital mortality and intensive care utilization commonly focus on patient rescue, where deteriorating patients are systematically identified and intervened upon. Patient rescue is known to depend on hospital context inclusive of technologic environment, structural features, and hospital organizational behavioral features. With widespread adoption of electronic medical records, early warning score (EWS) systems, which assign points to clinical data elements, are increasingly promoted as a tool for timely patient rescue by referencing their prediction of patient deterioration. We describe the extent to which EWS intervention studies describe the hospital environment of the intervention—details that would be critical for hospital leaders attempting to determine the real-world utility of EWSs in their own hospitals. DATA SOURCES: We searched CINAHL, PubMed, and Scopus databases for English language EWS implementation research published between 2009 and 2021 in adult medical-surgical inpatients. STUDY SELECTION: Studies including pediatric, obstetric, psychiatric, prehospital, outpatient, step-down, or ICU patients were excluded. DATA EXTRACTION: Two investigators independently reviewed titles/abstracts for eligibility based on prespecified exclusion criteria. DATA SYNTHESIS: We identified 1,434 studies for title/abstract screening. In all, 352 studies underwent full-text review and 21 studies were summarized. The 21 studies (18 before-and-after, three randomized trials) detailed 1,107,883 patients across 54 hospitals. Twelve reported the staff composition of an EWS response team. Ten reported the proportion of surgical patients. One reported nursing ratios; none reported intensive care staffing with in-house critical-care physicians. None measured changes in bed utilization or availability. While 16 qualitatively described resources for education/technologic implementation, none estimated costs. None described workforce composition such as team stability or culture of safety in the hospitals. CONCLUSIONS: Despite hundreds of EWS-related publications, most do not report details of hospital context that would inform decisions about real-world EWS adoption. To make informed decisions about whether EWS implementation improves hospital quality, decision-makers may require alternatives such as peer networks and implementation pilots nested within local health systems.
SAFETY AND THERAPEUTIC EFFECTS OF ORALLY ADMINISTERED AKST4290 IN NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Stewart, Michael W., Newman, Erin M. , Jeffords, Elizabeth, Sikorski, Bartosz L. , Rawner, Esther, Newman, Erin M , Garg, Seema , Konopińska, Joanna , Jackson, Sam

Mayo Clinic

Retina | February 21, 2022 | Volume: 42 | Issue: 6 | Pages: 1038-1046

10.1097/iae.0000000000003446 | PMID 35537111 Get It

Purpose: To evaluate the safety and therapeutic effects of orally administered AKST4290 (formerly BI 144807 and ALK4290) in treatment-naive patients with neovascular age-related macular degeneration. Methods: In this prospective, multicenter, open-label Phase 2a pilot clinical study, 30 patients with newly diagnosed neovascular age-related macular degeneration self-administered AKST4290 (400 mg) orally twice daily for 6 weeks. Patients were examined weekly for safety, to measure best-corrected visual acuity (BCVA), and to perform exploratory morphologic assessments. The primary endpoint was the mean change in BCVA from baseline to end of treatment, and the secondary endpoint was safety. Exploratory endpoints investigated potential changes in macular morphology. Results: Mean BCVA improved by +7.0 letters (95% CI, 2.2–11.7); 24 patients (82.8%) had stable or improved BCVA, with 6 (20.7%) gaining ≥15 letters. No patients experienced severe or serious adverse events. Conclusion: In this 6-week study, AKST4290 treatment was associated with improved BCVA scores in patients with treatment-naive neovascular age-related macular degeneration. All adverse events were mild or moderate in severity and no safety issues were identified. Treatment of neovascular age-related macular degeneration with AKST4290 warrants further investigation in randomized, placebo-controlled trials.
Towards Defining Morphologic Parameters of Normal Parous and Nulliparous Breast Tissues by Artificial Intelligence
Ogony, Joshua, Bel, Thomas de , Kachergus, Jennifer M., Thompson, E. Aubrey , Degnim, Amy C., Ruddy, Kathryn J. , Hilton, Tracy, Vachon, Celine M. , White, Launia J. , Moore, Raymond M. , Carter, Jodi M. , Jensen, Matthew L. , Henry, Jill E. , Storniolo, Anna Maria , Laak, Jeroen van der , Carter, Jodi , Radisky, Derek C. , Degnim, Amy C. , Stallings‐Mann, Melody , Vachon, Celine M. , Hoskin, Tanya L. , Heckman, Michael G. , Vierkant, Robert A. , Jensen, Matthew, Pacheco-Spann, Laura M. , Winham, Stacey J. , Sherman, Mark E.

Mayo Clinic

No container title available | February 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1359557/v1 Get It

Abstract Background:Breast terminal duct lobular units (TDLUs), the source of most breast cancer (BC) precursors, are shaped by age-related involution, a gradual process, and postpartum involution (PPI), a dramatic inflammatory process that restores baseline microanatomy after weaning. Dysregulated PPI is implicated in the pathogenesis of postpartum BCs. We propose that assessment of TDLUs in the postpartum period may have value in risk estimation, but characteristics of these tissues in relation to epidemiological factors are incompletely described.Methods: Using validated Artificial Intelligence and morphometric methods, we analyzed digitized images of tissue sections of normal breast tissues stained with hematoxylin and eosin from donors <45 years from the Komen Tissue Bank (180 parous and 545 nulliparous). Metrics assessed by AI, included: TDLU count; adipose tissue fraction; mean acini count/TDLU; mean dilated acini; mean average acini area; mean “capillary” area; mean epithelial area; mean ratio of epithelial area versus intralobular stroma; mean mononuclear cell count (surrogate of immune cells); mean fat area proximate to TDLUs and TDLU area. We compared epidemiologic characteristics collected via questionnaire by parity status and race, using a Wilcoxon rank sum test or Fisher’s exact test. Histologic features were compared between nulliparous and parous women (overall and by time between last birth and donation [ recent birth: ≤5 years versus remote birth: >5 years]) using multivariable regression models.Results:Normal breast tissues of parous women contained significantly higher TDLU counts and acini counts, more frequent dilated acini, higher mononuclear cell counts in TDLUs and smaller acini area per TDLU than nulliparas (all multivariable analyses p<0.001). Differences in TDLU counts and average acini size persisted for >5 years postpartum whereas increases in immune cells were most marked <5 years of a birth. Relationships were suggestively modified by several other factors, including demographic and reproductive characteristics, ethanol consumption and breastfeeding duration. Conclusions:Our study identified sustained expansion of TDLU numbers and reduced average acini area among parous versus nulliparous women and notable increases in immune responses within five years following childbirth. Further, we show that quantitative characteristics of normal breast samples vary with demographic features and BC risk factors.
Antibiotic Prophylaxis with Cefazolin Is Associated with Lower Shoulder Periprosthetic Joint Infection Rates Than Non-Cefazolin Alternatives
Marigi, Erick M. , Bartels, D , Yoon, Joo Hee , Sperling, John W. , Sánchez‐Sotelo, Joaquín , Bartels, Douglas W , Sanchez-Sotelo, J. , Marigi, Erick , Yoon, Joo Hee , Sperling, John W

Mayo Clinic

Journal of Bone and Joint Surgery | February 21, 2022 | Volume: 104 | Issue: 10 | Pages: 872-880

10.2106/jbjs.21.00445 | PMID 35188900 Get It

Background: Although prophylactic antibiotics are considered the standard of care, data with regard to the comparative efficacy of specific antibiotics in the prevention of periprosthetic joint infection (PJI) have remained limited. This study evaluated whether perioperative antibiotic choice affects rates of PJI development in shoulder arthroplasty. Methods: From 2000 to 2019, all primary shoulder arthroplasty types (hemiarthroplasty, anatomic total shoulder arthroplasty, reverse shoulder arthroplasty) performed for elective and trauma indications with perioperative antibiotic data and a minimum follow-up of 2 years were identified from a single institution. Demographic characteristics, PJI risk factors, and PJI-free survivorship data were retrieved. Multivariable analyses were conducted to determine the association between the antibiotic administered and the development of PJI. Results: Of 7,713 shoulder arthroplasties, cefazolin was administered in 6,879 procedures (89.2%) and non-cefazolin antibiotics consisting of vancomycin (465 procedures [6.0%]), clindamycin (345 procedures [4.5%]), and alternative regimens (24 procedures [0.31%]) were administered in 834 procedures (10.8%). PJIs occurred in 101 shoulder arthroplasties (1.3%), with Cutibacterium acnes as the most common pathogen (44 procedures [43.6%]). PJI-free survivorship was greater in shoulder arthroplasties in which cefazolin was administered compared with those in which non-cefazolin antibiotics were administered, with 0.91% greater survival free of PJI at 1 month, 1.4% at 1 year, and 2.7% at 15 years (p < 0.001). Cefazolin administration, compared with non-cefazolin administration, was associated with a 69% reduction in all-cause PJI risk and a 78% reduction in C. acnes PJI risk (p < 0.001). A higher risk of PJI for both groups was observed with vancomycin; the hazard ratio [HR] was 2.32 (95% confidence interval [CI], 1.22 to 4.40; p = 0.010) for all-cause PJI and 2.94 (95% CI, 1.12 to 7.49; p = 0.028) for C. acnes PJI. A higher risk of PJI was also observed for both groups for clindamycin; the HR was 5.07 (95% CI, 2.83 to 9.05; p < 0.001) for all-cause PJI and 8.01 (95% CI, 3.63 to 17.42; p < 0.001) for C. acnes PJI. Conclusions: In primary shoulder arthroplasty, cefazolin administration was associated with a significantly lower rate of PJI compared with non-cefazolin alternatives, including both vancomycin and clindamycin. These risk discrepancies were observed across all infectious pathogens and may be considered even greater when C. acnes was the infecting bacterium. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats
Hosseinzadeh, Rezvan , Liang, Jackson J. , Mansouri, Razieh, Hosseini, Mohammad , Moghadamnia, Ali Akbar , Liang, Jackson , Barary, Mohammad , Sio, Terence T. , Kazemi, Sohrab

Mayo Clinic

No container title available | February 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1359440/v1 Get It

Abstract Background 5- Fluorouracil (5-FU) is one of the most common chemotherapeutic agents used in treating solid tumors, and the 5-FU-induced cardiotoxicity is the second cause of cardiotoxicity induced by chemotherapeutic drugs. Propolis (Pro) has vigorous anti-inflammatory activity. Its cardio-protective characteristic against doxorubicin-induced cardiotoxicity was previously proven. The current study aimed to appraise the effect of Pro on 5-FU-induced cardiotoxicity in rats. Methods Twenty-four male Wistar rats were divided into four groups: Control, 5-FU, 5-FU + Pro 250 mg/kg, and 5-FU + Colchicine (CLC) 5 mg/kg. Different hematological, serological, biochemical, histopathological, and molecular assays were performed to assess the study aim. Moreover, rat myocardium (H9C2(2 − 1)) and human skin fibroblast (HNFF-P18) cell lines were also used to assess this protective effect in-vitro. Results 5-FU resulted in significant cardiotoxicity represented by an increase in malondialdehyde (MDA) levels, cyclooxygenase-2 (COX-2), and tumor necrosis factor-α (TNF-α) expression, cardiac enzyme levels, and histopathological degenerations. 5-FU treatment also decreased bodyweight, total anti-oxidant capacity (TAC), catalase (CAT) levels, blood cell counts, and hemoglobin (Hb) levels. In addition, 5-FU disrupted ECG parameters, including increased elevation in the ST-segment and increased QRS complex and QTc duration. Treating with Pro reduced oxidative stress, cardiac enzymes, histopathological degenerations, and COX-2 expression in cardiac tissue alleviated ECG disturbances and increased the number of blood cells and TAC levels. Moreover, 5-FU-induced bodyweight loss was ameliorated after treatment with Pro. Conclusion Our results demonstrated that treatment with Pro significantly improved cardiotoxicity induced by 5-FU in rats.
Role of the arterial baroreflex in the sympathetic response to hyperinsulinemia in adult humans
McMillan, Neil J. , Soares, Rogério N. , Harper, Jennifer L. , Shariffi, Brian , Moreno‐Cabañas, Alfonso , Manrique‐Acevedo, Camila , Padilla, Jaume , Limberg, Jacqueline K. , Curry, Timothy B. , Manrique-Acevedo, Camila M , Padilla, Jaume , Limberg, Jacqueline K

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | February 21, 2022 | Volume: 322 | Issue: 4 | Pages: E355-E365

10.1152/ajpendo.00391.2021 | PMID 35187960 Get It

We hypothesized that elevation in muscle sympathetic nervous system activity (MSNA) during hyperinsulinemia is mediated by its peripheral vasodilator effect on the arterial baroreflex. Using three separate protocols in humans, we observed increases in both MSNA and cardiac output during hyperinsulinemia, which we attributed to the baroreflex response to peripheral vasodilation induced by insulin. Results show that peripheral vasodilation induced by insulin contributes to increased MSNA during hyperinsulinemia.
Predictors of Recurrence After Sub-total or Near-total Resection of Vestibular Schwannoma: Importance of Tumor Volume and Ventral Extension
Manzoor, Nauman F., Nassiri, Ashley M., Sherry, Alexander D., Dang, Sabina, Yancey, Kristen L., Monsour, Meredith, Perkins, Elizabeth L., Khattab, Mohamed H., Thompson, Reid C., O’Malley, Matthew R., Bennett, Marc L., Rivas, Alejandro C., Haynes, David S., Sherry, Alexander D. , Yancey, Kristen L. , Sherry, Alexander D , Manzoor, Nauman F., Nassiri, Ashley M., Dang, Sabina, Monsour, Meredith A. , Perkins, Elizabeth L., Khattab, Mohamed H., Thompson, Reid C., O’Malley, Matthew R., Bennett, Marc L., Rivas, Alejandro C., Haynes, David S.

Mayo Clinic

Otology & Neurotology | February 21, 2022 | Volume: 43 | Issue: 5 | Pages: 594-602

10.1097/mao.0000000000003477 | PMID 35184072 Get It

Objective: To evaluate the predictors of remnant tumor regrowth and need for salvage therapy after less than gross total resection (GTR) of vestibular schwannoma (VS). Study Design: Retrospective chart review. Setting: Tertiary neurotologic referral center. Patients: Patients who underwent VS resection between 2008 and 2019 either with GTR, near total resection (NTR), and subtotal resection (STR). Interventions: Microsurgical resection, salvage radiosurgery. Main Outcome Measures: Regrowth free interval, salvage free interval, tumor doubling rate. Results: Three hundred eighty five cases (GTR = 236, NTR = 77, and STR = 71) from 2008 to 2019 were included. STR cohort had much larger and complex tumors with significant differences in tumor volume, ventral extension and brainstem compression (p < 0.001). On single predictor analysis, tumor volume, ventral extension, brainstem compression as well as STR strategy was associated with significant increased risk of regrowth and need for salvage therapy. Multivariate analysis revealed STR strategy as significant predictor of regrowth (hazard ratio 3.79, p < 0.0005). Absolute remnant volume and extent of resection (EOR) did not predict regrowth. A small proportion of cases (NTR = 4%, STR = 15%) eventually needed salvage radiosurgery with excellent ultimate local tumor control with no known recurrence to date. Conclusions: Conservative surgical strategy employing NTR or STR can be employed safely in large and complex VS. While there is increased risk of regrowth in the STR cohort, excellent local control can be achieved with appropriate use of salvage radiosurgery. No disceret radiologic or operative predictors of regrowth were identified.